ArticleJournal of neuro-oncology2021

PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.

Antonio Dono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.